Home First China Bio-Computing Conference Registration Now Open!

First China Bio-Computing Conference Registration Now Open!

Mar 29, 2021 09:50 CST Updated 09:50


Conference Introduction



The 1st China Bio-Computing Conference, co-hosted by Biotope and Bohe Innovation, will be held at the Suzhou International Expo Center on May 10–11, 2021. The event aims to unite partners from the biotechnology and information technology (BT & IT) industries to jointly build a multi-party integrated industrial ecosystem, achieving comprehensive AI empowerment of the biotechnology sector through information exchange and resource sharing.


The conference will invite over 100 industry scientists, opinion leaders, senior government officials, and corporate partners from the field of biological computing to jointly define biological computing from multiple dimensions, including industry needs, drivers, current challenges, and future prospects.


The co-organizers of this conference are the Baihua Association, the New Drug Founders Club, and BiG. The guiding unit is the Administrative Committee of Suzhou Industrial Park, and VCBeat serves as the supporting media partner.


Agenda



May 10 (Morning)


>>>>

Biocomputing: A Roundtable Discussion


1. The Converged Ecosystem of BT and IT

2. Application of AI High-Performance Computing in Physics-Based Drug Design

3. When Will Biological Computing Reach Its "Singularity Moment"?

4. AI from the Perspective of Life Sciences

5. Cross-disciplinary Integrated New Drug R&D Model

6. New Paradigms in Translational Medicine Research Driven by Emerging Omics Technologies


May 10 (Afternoon)


>>>>

Biocomputing and New Data


1. Application of Cutting-Edge Epigenetic Technologies in Tumor Detection

2. Changes in Data Dimensions and Analytical Methods Driven by the Development of Spatial Transcriptomics Technology

3、High-Throughput Gene Sequencing Screening Protocol and Application for Neonatal Genetic Disorders in China

4、Research Sharing of Clinical Omics Data

5、High-Throughput Data Acquisition for AI-Based Product Development


May 10 (Afternoon)


>>>>

Biocomputing and New Algorithms


1. Computational Biology Methods for Drug Development Scenarios

2. A Brief Discussion on the Future Development of Quantum Computing

3. Algorithmic Architectures and Underlying Platforms Required in the Biopharmaceutical Sector

4. Computational Models and Simulation Algorithms for Biomacromolecules

5. Development of Macromolecular Force Fields



May 11 (All Day)


>>>>

Computer-Aided Drug Design


1. AI-Accelerated PROTAC Drug Design

2. Application of GANs in Small-Molecule Drug Screening

3. AI-Driven Allosteric Drug Design

4. Applications of AIDD in MNCs

5. AI Platform Empowers Kinase Drug Development

6. Neoantigen Recognition and Cell Therapy Development

7. Where Is AI-Driven Macromolecular Drug Design Headed?



May 11 (All Day)

 

>>>>

Interdisciplinary Exploration in Biological Computing


1. AI + Electron Microscopy Image Analysis

2. How Deep Learning Technologies Facilitate Antibiotic Discovery and the Field of Synthetic Biology

3. From Research to Enterprise: How to Implement Technology Applications Using Interdisciplinary Thinking

4. Exploring the Incubation Model of AI + Capital

5. Applications of Brain Organoids in Research on CNS Diseases

6. AI + Brain Functional Atlas

7. Has the Era of AI + Medical Imaging Passed?


Preliminary Confirmed Attendees


*In no particular order*

Academician Weinan E, Founding Dean of the Beijing Institute for Big Data Research and the School of Big Data at the University of Science and Technology of China

Yi Gong, Academician, President of Westlake University

Academician Dong Chen, Professor at Shanghai Jiao Tong University School of Medicine, Director of the Institute for Immunology at Tsinghua University

James Collins, Professor of Biological Engineering at MIT and a pioneer in synthetic biology

Robert Langer, Member of the U.S. National Academies of Sciences, Engineering, and Medicine; David H. Koch Institute Professor at the Massachusetts Institute of Technology

Zhang Zemin, Tenured Professor at the School of Life Sciences, Peking University; Scientific Advisor to BioBai Intelligence; Expert in Single-Cell Analysis

He Chuan, Tenured Professor in the Department of Chemistry at the University of Chicago, Epigenetics Expert

Guo Tiannan, Distinguished Researcher at Westlake University, Proteomics Expert

Fan Rong: Tenured Professor at Yale University, Advisor to Singleron, and Expert in Single-Cell Technology

Huang Jing, Head of the Laboratory for Computational Biophysics and Drug Design, School of Life Sciences, Westlake University; Expert in Molecular Force Fields

Jianfeng Pei, Researcher at the Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University; Founder of Infinity Pharmaceuticals

Li Rui, Research Fellow at the Department of Biomedical Engineering, School of Medicine, Tsinghua University; Expert in Biomedical Imaging

Li Honglin, Professor at the School of Pharmacy, East China University of Science and Technology; Expert in Drug Design and Target Discovery

Zhang Lianshan, Vice President of Hengrui Medicine and Head of Global R&D

Yang Qing, Co-CEO of WuXi AppTec

Robin Li, Founder, Chairman and CEO of Baidu; Founder & Chairman of Biotope

Xu Ting, Chairman and CEO of Alphamab Oncology

Wen Shuhao, Co-Founder and Chairman of XtalPi

Cai Jiexing, Senior Vice President of WuXi Biologics

Li Jian, Vice President of Domestic New Drug R&D Services at WuXi AppTec

Xie Changyu, Senior Researcher at Tencent Quantum Laboratory

Bingshi Guo, CSO of I-Mab Biopharma

Lai Caida, CEO of Metagenomi

Yu Zhengtian, CTO of Yudao Bio

Zhang Linfeng, CTO of DP Technology

Peng Songming, CEO of Neowise

Meng Xun, Founder and CEO of Puzhong Discovery

Wei Kecheng, CEO of Ubrain Galaxy

Cui Hao, Founder and CEO of Bota Bio

Chen Hao, CEO of Innovel

Xia Qiangwei, CEO of Yongdao Zhiyuan

Shi Yaozhou, CEO of Baimi Pharmaceutical

Wu Chun, Founder and CEO of Baidao Pharma

Chen Tao, CEO of Younuozhen

Sun Jinquan, CEO of Vosheng Biotech

Sun Minmin, Founder and CEO of Yi Mu Feng


Conference Guide


>>>>

Conference Time and Venue


Conference Date: May 10-11, 2021

Venue: Suzhou International Expo Center

Conference Scale: 500 attendees on-site, with simultaneous global live streaming


>>>>

Registration and Payment


Registration and Payment: Online registration and payment are required.

Early Bird Ticket: RMB 1,688/person (payment by April 15)

Regular Ticket: RMB 2,999/person (payment after April 15)

Registration Link: Please scan the QR code below


image.png